Ubs Group Ag Ice Cure Medical Ltd. Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Ice Cure Medical Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 2,162 shares of ICCM stock, worth $2,421. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,162Holding current value
$2,421% of portfolio
0.0%Shares
11 transactions
Others Institutions Holding ICCM
# of Institutions
15Shares Held
130KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA40.5KShares$45,3070.0% of portfolio
-
Xtx Topco LTD London, X021.9KShares$24,5010.0% of portfolio
-
Lpl Financial LLC Fort Mill, SC18.9KShares$21,1400.0% of portfolio
-
Foundations Investment Advisors, LLC15KShares$16,8000.0% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.3KShares$12,6560.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $41.3M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.